NEW YORK (CBS.MW) -- ID Biomedical shares gained more than 12 percent to $17.48 after the company reported positive preliminary results of a study of its FluNsure influenze vaccine. The company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback